CHANGMAO BIO(00954.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 4.93 million, loss narrowed by 80.88% YoY
NewTimeSpace News: August 18, 2026, CHANGMAO BIO(00954.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 289.55 million, increased by 6.34% YoY; Net Profit stood at loss of CNY 5.09 million, loss narrowed by 80.4% YoY; Profit Attributable to Shareholders stood at loss of CNY 4.93 million, loss narrowed by 80.88% YoY; Basic Earnings Per Share (EPS) stood at loss of CNY cents 0.9.
In terms of profitability, CHANGMAO BIO Gross Profit changed from CNY 13.15 million in the same period last year to CNY 42.54 million in the current period, increased by CNY 29.39 million; gross profit margin changed from 4.83% in the same period last year to 14.69% in the current period, increased by 9.86 percentage points; net profit changed from loss of CNY 25.99 million in the same period last year to loss of CNY 5.09 million in the current period, increased by CNY 20.89 million; net profit margin changed from -9.54% in the same period last year to -1.76% in the current period, increased by 7.78 percentage points.
In terms of earnings quality, CHANGMAO BIO Operating Profit changed from loss of CNY 19.49 million in the same period last year to CNY 6.01 million in the current period, increased by CNY 25.49 million; Operating Profit Margin changed from -7.16% in the same period last year to 2.07% in the current period, increased by 9.23 percentage points; Net Cash Flow from Operating Activities changed from cash inflow of CNY 15.36 million in the same period last year to cash inflow of CNY 43 million in the current period, increased by CNY 27.63 million; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from 5.64% in the same period last year to 14.85% in the current period, increased by 9.21 percentage points.
In terms of financial soundness, CHANGMAO BIO Debt-to-Asset Ratio changed from 54.68% in the same period last year to 55.04% in the current period, increased by 0.36 percentage points; Total Equity changed from CNY 557.352 million in the same period last year to CNY 511.073 million in the current period, decreased by CNY 46.28 million; Cash and Cash Equivalents changed from CNY 58.581 million in the same period last year to CNY 36.799 million in the current period, decreased by CNY 21.78 million; Current Liabilities changed from CNY 584.48 million in the same period last year to CNY 519.34 million in the current period, decreased by CNY 65.14 million; Quick Ratio changed from 0.27 in the same period last year to 0.22 in the current period, decreased by 0.05 percentage points.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
